Invitation to presentation of the Q1 report 2025

Stockholm – May 13, 2025 – Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, will publish the report for the first quarter 2025, at 08:00 CET on May 15, 2025.

Investors, financial analysts, and media are invited to participate in a webcast and a subsequent Q&A session on May 15 at 09:00 CET.
 
The presentation will be hosted by Sofia Heigis, CEO, together with Henrik Bergentoft, CFO. The webcast will be held in English and published on the website of Oncopeptides – www.oncopeptides.com – in conjunction with the start of the presentation.

Information for participants
If you wish to participate via webcast please use the link below.
https://oncopeptides.events.inderes.com/q1-report-2025/register
 
If you wish to participate via teleconference please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
https://conference.inderes.com/teleconference/?id=5005188

Datum 2025-05-13, kl 09:40
Källa MFN
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.
Cashback är begränsad till högst $100. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.